| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| MAA |
|
microphthalmia or anophthalmia and associated anomalies
|
|
|
0.666 |
0.577 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| THM |
|
thymoma
|
|
|
0.686 |
0.500 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| LEPQTL1 |
|
Leptin, serum levels of
|
|
|
0.638 |
0.385 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| RNU1-1 |
|
RNA, U1 small nuclear 1
|
|
|
0.608 |
0.731 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| CPAT1 |
|
cerebral palsy, ataxic 1
|
|
|
0.674 |
0.654 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| LINC00599 |
|
long intergenic non-protein coding RNA 599
|
|
|
0.760 |
0.192 |
| ZEB1-AS1 |
|
ZEB1 antisense RNA 1
|
|
|
0.636 |
0.423 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| HCCAT5 |
|
hepatocellular carcinoma associated transcript 5
|
|
|
0.716 |
0.462 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |